Browse through our recent news and keep up to date with the latest on what’s been happening at Neuroclin Glasgow.
A new Alzheimer’s Research Study – ASPECT™
Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming? We’re continuing with our mission to help find a cure for Alzheimer’s disease and have now launched a new Alzheimer’s disease research study – ASPECT™ What is the ASPECT™ Study? The purpose of the ASPECT … Continued
Top 5 Dementia Friendly Christmas Gifts
What Gifts You Can Give To Make Christmas Dementia Friendly Christmas is a time for families and festivities, but it can also bring new challenges for people affected by Dementia and Alzheimer’s disease. When it comes to finding the perfect gift for a senior with Alzheimer’s or Dementia, it is not always easy. … Continued
A new Alzheimer’s Research Study – Apollo E4
Are you or someone you know struggling with memory loss? The Apollo E4 Alzheimer’s Disease Research Study We’re continuing with our mission to help find a cure for Alzheimer’s disease and have now launched a new Alzheimer’s disease research study – Apollo E4. What is the Apollo E4 study? The aim of … Continued
Our Current Studies – November 2020
While everything in the world might be on hold right now, our mission to help find a cure for Alzheimer’s disease certainly is not. We have recently re-opened our doors to our new state-of the -art facility in Excel House, Eurocentral and have started welcoming participants and their families in for their appointments for our … Continued
Glasgow Memory Clinic are Attending the Alzheimer’s Association International Conference®
We are pleased to announce that our Development Director Alison Cranmer and Senior Research Physician Dr Jennifer Lynch will be attending the annual Alzheimer’s Association International Conference® (AAIC®), which will now be taking place virtually between the 27th and 31st of July. The AAIC® is the biggest international conference dedicated to advancing dementia science, which … Continued
Key takeaways of AAIC 2019
Earlier this month, we were delighted to attend the Alzheimer’s Association International Annual Conference held at the Convention Center in Los Angeles. About AAIC As always, this experience was incredibly insightful into new investigations and discoveries from around the world. The AAIC is the largest international meeting where investigators, clinicians and care providers gather … Continued
Hopes rise again for a drug to slow Alzheimer’s disease
Hopes are increasing again for a drug to alter the course of Alzheimer’s disease after decades of failures. An experimental therapy slowed mental decline by 30 percent in patients who got the highest dose in a mid-stage study. The drug from Eisai and Biogen did not meet its main goal in a study of 856 participants, so … Continued
Financial Times Seasonal Appeal 2017/18 supports Alzheimer’s Research UK & you can help
There is a misconception that dementia is just an inevitable part of getting older, but dementia (like Cancer and AIDS) is caused by diseases. Alzheimer’s disease has been the most common cause of dementia for over 40 years. There are more than half a million people in the UK with Alzheimer’s disease. Today nearly 47 … Continued
Glasgow Memory Clinic supports the Blythswood Care Christmas Shoebox Appeal for the third year in a row
Glasgow Memory Clinic has supported the Blythswood Care Christmas Shoebox Appeal since 2015, donating 99 boxes over the past three years. The boxes contain essentials such as hats, scarves and gloves, soap, toothpaste, brushes, toys and sweets. The shoe boxes are given to those less fortunate in a variety of countries including Albania, Bulgaria, Hungary, … Continued
On a mission with our new clinical study: MissionAD
Glasgow Memory Clinic conducts several different clinical trials including Early Trial, Engage and Daybreak. We are now pleased to offer the MissionAD clinical research programme. The MissionAD study is a clinical research programme that examines the effects of an investigational drug for the early stages of Alzheimer’s disease. Doctors are studying this investigational drug to see … Continued